263: Biogen's messy board, Laronde's data problem, & the downside of a boom episode artwork

EPISODE · Jun 15, 2023 · 39 MIN

263: Biogen's messy board, Laronde's data problem, & the downside of a boom

from The Readout Loud · host STAT

Our colleague Allison DeAngelis joins us to share her reporting on how the handsomely funded Laronde Therapeutics, billed as “Moderna 2.0,” ran into behind-the-scenes problems with its scientific data. We also discuss how Biogen's boardroom scandal has roiled a company that was supposed to be entering a new era.

Episode metadata supplied by the publisher feed · Published Jun 15, 2023

Embed this episode

NOW PLAYING

263: Biogen's messy board, Laronde's data problem, & the downside of a boom

0:00 39:57

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of The Readout Loud?

This episode is 39 minutes long.

When was this The Readout Loud episode published?

This episode was published on June 15, 2023.

Can I download this The Readout Loud episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!